Zielinska, D., et cols. Food-Origin Lactic Acid Bacteria May Exhibit Probiotic Properties: Review. Biomed Res Int 2018; 2018 (ID 5063185): 15 pages.
Olveira, G.; González-Molero, I. Actualización de probióticos, prebióticos y simbióticos en nutrición clínica. Endocrinol Nutr. 2016; 63(9): 482–494.
Gimeno Creus, E. Alimentos prebióticos y probióticos. Rev Offarm 2004; 23(5): 90–98.
Bedford, A.; Gong, J. Implications of butyrate and its derivatives for gut health and animal production. Anim Nutr 2018; 4(2): 151–159.
Deschasaux, M.; Bouter, K.E.; Prodan, A.; Levin, E.; Groen, A.K.; Herrema, H.; Tremaroli, V.; Bakker, G.J.; Attaye, I.; Pinto-Sietsma, S.J.; Van Raalte, D.H.; Snijder, M.B.; Nicolaou, M.; Peters, R.; Sanders, M.E.; Benson, A.; Lebeer, S.; Merenstein, D.J.; Klaenhammer, T.R. Shared mechanisms among probiotic taxa: implications for general probiotic claims. Curr. Opin. Biotechnol. 2018; 49: 207–216.
Bottacini, F.; Van Sinderen, D.; Ventura, M. Omics of bifidobacteria: research and insights into their health-promoting activities. Biochem. J. 2017, 474, 4137–4152.
Zwinderman, A.H.; Bäckhed, F.; Nieuwdorp, M. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography, Nat Med. 2018; 24(10): 1526–1530
Basu, S.; Yoffe, P.; Hills, N.; Lustig, R.H. The Relationship of Sugar to Population-Level Diabetes Prevalence: An Econometric Analysis of Repeated Cross-Sectional Data. PLoS ONE 2013; 8(2): e57873. doi:10.1371/journal. pone.0057873.
Jandhyala, S.M.; Talukdar, R.; Subramanyam, C.; Vuyyuru, H.; Sasikala, M.; Reddy, D.N. Role of the normal gut microbiota. World J. Gastroenterol. 2015, 21, 8836–8847.
Tan, H.; Zhai, Q.; Chen, W. Investigations of Bacteroides spp. towards next-generation probiotics. Food Res. Int. 2019, 116, 637–644.
Lebeer, S.; Vanderleyden, J.; De Keersmaecker, S.C.J. Host interactions of probiotic bacterial surface molecules: Comparison with commensals and pathogens. Nat. Rev. Microbiol. 2010, 8, 171–184.
Sarkar, A.; Mandal, S. Bifidobacteria—Insight into clinical outcomes and mechanisms of its probiotic action. Microbiol. Res. 2016, 192, 159–171.
National Institutes of Health. The Human Microbiome Project. [Internet]. [Consultado 21 Ene 2019]. Disponible en: https://hmpdacc.org/
Fontané, L., et cols. Influence of the microbiota and probiotics in obesity. Clin Investig Arterioscler 2018; 30(6): 271–279.
Icaza-Chávez, M.E. Gut microbiota in health and disease. Rev Gastroenterol Mex 2013; 78(4): 240-248.
MetaHIT Consortium. Metagenomics of the Human Intestinal Tract. [Internet]. [Consultado 26 Mar 2019]. Disponible en: http://www. metahit.eu/
Han, Y.; Wu, W.; Zheng, H.M.; Li, P.; McDonald, D.; Sheng, H.F.; Chen, M.X.; Chen, Z.H.; Ji, G.Y.; Zheng, Z.D.; Mujagond, P.; Chen, X.J.; Rong, Z.H.; Chen, P.; Lyu, L.Y.; Wang, X.; Wu, C.B.; Yu, N.; Xu, Y.J.; Yin, J.; Raes, J.; Knight, R.; Ma, W.J.; Zhou, H.W. Regional variation limits applications of healthy gut microbiome reference ranges and disease models, Nat Med. 2018; 24(10): 1532–1535.
Azpiroz, M.B.; Castro, M.S.; Ponzio, R.; Canellada, A.M.; Manghi, M.A.; Sparo, M.D.; Díaz, A.M.; Molina, M.A. Probiotic activity of Enterococcus faecalis CECT7121: effects on mucosal immunity and intestinal epithelial cells. J. Appl. Microbiol. 2016, 121, 1117–1129.
Hallen-Adams, H.E.; Suhr, M.J. Fungi in the healthy human gastrointestinal tract. Virulence 2017, 8, 352–358.
Zmora, N.; Soffer, E.; Elinav, E. Transforming medicine with the microbiome. Sci. Transl. Med. 2019, 11, eaaw1815.
Ruppé, E.; Ghozlane, A.; Tap, J.; Pons, N.; Álvarez, A.-S.; Maziers, N.; Cuesta, T.; Hernando-Amado, S.; Clares, I.; Martínez, J.L., et al. Prediction of the intestinal resistome by a three-dimensional structure-based method. Nat. Microbiol. 2019, 4, 112–123.
Sanz, Y.; Romaní-Perez, M.; Benítez-Páez, A.; Portune, K.J.; Brigidi, P.; Rampelli, S.; Dinan, T.; Stanton, C.; Delzenne, N.; Blachier, F., et al. Towards microbiome-informed dietary recommendations for promoting metabolic and mental health: Opinion papers of the MyNewGut project. Clin. Nutr. 2018, 37, 2191–2197.
Honda, K.; Littman, D.R. The microbiota in adaptive immune homeostasis and disease. Nature 2016, 535, 75–84.2.
Takaishi, H.; Matsuki, T.; Nakazawa, A.; Takada, T.; Kado, S.; Asahara, T.; Kamada, N.; Sakuraba, A.; Yajima, T.; Higuchi, H., et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int. J. Med. Microbiol. 2008, 298, 463–472.
Kim, D.; Zeng, M.Y.; Núñez, G. The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Exp. Mol. Med. 2017, 49, e339.
Jandhyala, S.M.; Talukdar, R.; Subramanyam, C.; Vuyyuru, H.; Sasikala, M.; Reddy, D.N. Role of the normal gut microbiota. World J. Gastroenterol. 2015, 21, 8836–8847.5.
Cani, P.D.; Van Hul, M.; Everard, A.; Rastelli, M.; Lefort, C.; Depommier, C. Microbial regulation of organismal energy homeostasis. Nat. Metab. 2018, 1, 34–46.